Better AI Inference Stock to Own: Nvidia or Cerebras?
Bởi Maksym Misichenko · Nasdaq ·
Bởi Maksym Misichenko · Nasdaq ·
Các tác nhân AI nghĩ gì về tin tức này
The panelists agree that neither Nvidia nor Cerebras has proven inference economics at scale. Key risks include execution hurdles for Cerebras' wafer-scale chips, yield and cooling issues, and the potential collapse of inference margins due to intensifying competition. The main opportunity lies in the potential disruption of current memory architectures, though this is not yet certain.
Rủi ro: Execution hurdles for Cerebras' wafer-scale chips
Cơ hội: Potential disruption of current memory architectures
Phân tích này được tạo bởi đường dẫn StockScreener — bốn LLM hàng đầu (Claude, GPT, Gemini, Grok) nhận các lời nhắc giống hệt nhau với các biện pháp bảo vệ chống ảo tưởng tích hợp. Đọc phương pháp →
Cerebras and Nvidia are both using SRAM in their inference chips.
However, Cerebras is making massive-sized chips, while Nvidia has incorporated normal-sized LPUs into its chip ecosystem.
While large language model (LLM) training dominated the first phase of artificial intelligence (AI), inference is eventually expected to become the much larger market.
While LLM training is compute-heavy and more technically challenging, inference tends to be memory-centric and needs to be more cost-efficient given that it's an ongoing process. Traditionally, graphics processing units (GPUs) and other AI accelerators are packaged with high-bandwidth memory (HBM) to help optimize their performance in this area.
Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »
However, Nvidia (NASDAQ: NVDA), through its recent "acquisition" of Groq, and Cerebras Systems (NASDAQ: CBRS) are now looking toward on-chip SRAM (static random-access memory) to speed up AI workloads for inference. This is a new approach, and both companies are using SRAM in a much different way. While using SRAM can dramatically increase inference speeds, it is physically bulky, which creates some trade-offs between chip size, memory capacity, and the data center infrastructure required to power and cool the chips.
Let's look at the two approaches and see which semiconductor stock looks better positioned to become the inference market leader.
To deal with the physical bulkiness of SRAM, Cerebras creates massive wafer-sized chips that can fit both a large amount of computing power and SRAM onto a single chip. However, this comes with additional issues that need to be addressed.
The first is that the chip manufacturing process is complex, and defects are common. The reason Taiwan Semiconductor Manufacturing has become a virtual monopoly in advanced chip manufacturing is that it can produce advanced chips at high yields, but even its goal for its newest technology is a yield of around 80%. When you're looking at very expensive, wafer-sized chips, though, that type of yield doesn't cut it. To address this issue, Cerebras adds extra cores to help it work around any defects to its chips.
In addition, its chips need special cooling and power management, which is why it doesn't sell them individually, instead only selling or renting them as part of its complete end-to-end server rack CS-3 system. While the company boasts that its systems can perform inference 15 times faster than a GPU, everything involved leads to a very expensive premium solution.
With its $20 billion "acquisition" of Groq, Nvidia gained access to the company's language processing units (LPUs) designed for inference. While LPUs also use SRAM, they are ordinary-sized chips. The trade-off is that LPUs use a very small amount of SRAM on each chip, so they have to be interconnected with other LPUs in a massive, complex cluster. This reduces efficiency.
By comparison, Cerebras' chips are six times faster. They also tend to be very inflexible and can only be used for inference.
However, the one big benefit of the Nvidia deal is that it has incorporated LPUs into its CUDA software platform and designed complete rack systems using both its GPUs and LPUs specifically for inference. GPUs packaged with HBM can handle the prefill phase of understanding a user's prompt, while LPUs can then take over the decode phase of providing the response. Because LPUs use SRAM memory, they can respond with almost no lag.
Cerebras has an opportunity to turn the inference market on its head and has a large commitment from OpenAI that will fuel huge growth. However, the stock is trading at a huge valuation right out of the gate (more than 100 times trailing sales) and needs to prove it can become more than a niche player.
Nvidia, on the other hand, is already the well-established leader in LLM training. Its "acquisition" of Groq, meanwhile, looks like a great move that should help it become an important player in the inference market. By being able to combine its GPUs with LPUs in the same server, the company has found a way to take a niche product and bring it to the mainstream. As such, I think Nvidia is the better buy of the two stocks.
Before you buy stock in Cerebras Systems, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Cerebras Systems wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $463,900! Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,294,401!
Now, it’s worth noting Stock Advisor’s total average return is 978% — a market-crushing outperformance compared to 211% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
**Stock Advisor returns as of May 31, 2026. *
Geoffrey Seiler has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Nvidia and Taiwan Semiconductor Manufacturing. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Bốn mô hình AI hàng đầu thảo luận bài viết này
"Nvidia's LPU clustering adds complexity that specialized SRAM designs like Cerebras can exploit in high-volume inference despite premium pricing."
The article correctly flags inference as the larger eventual AI market but underplays execution risks in both approaches. Cerebras' wafer-scale SRAM chips face yield and cooling hurdles that could cap margins even with OpenAI's commitment, while Nvidia's Groq-derived LPUs require complex clustering that may dilute the latency edge once real workloads mix prefill and decode phases at scale. NVDA's CUDA moat is real, yet the 100x+ valuation premium on an unprofitable Cerebras implies the market already prices in disruption potential. Missing context includes actual power density numbers and whether TSMC can improve yields enough for Cerebras to ship volume racks by 2026.
Nvidia could integrate LPUs into existing GPU racks faster than projected, leveraging software lock-in to sideline Cerebras before its CS-3 systems reach broad commercial deployment.
"Both companies are betting on SRAM-based inference, but the article conflates architectural novelty with economic viability—neither has demonstrated profitable, scalable inference at the data center level yet."
The article frames this as NVDA vs. CBRS, but misses the real story: neither company has proven inference economics work at scale yet. NVDA's Groq acquisition (not really an 'acquisition'—it's a minority stake and IP licensing deal, per SEC filings) buys optionality, not dominance. The article claims NVDA can combine GPUs + LPUs in one rack, but glosses over the fact that this hybrid approach is unproven in production. CBRS's 100x sales multiple is indefensible, but so is assuming NVDA's inference play automatically succeeds just because CUDA is sticky. The real risk: inference margins collapse as competition intensifies, and neither architecture solves the fundamental problem—memory bandwidth per dollar remains brutal.
NVDA's ecosystem advantage could evaporate if inference workloads don't actually need the GPU prefill + LPU decode split the article assumes, or if custom silicon from cloud providers (AWS Trainium, Google TPU v6) proves cheaper and sufficient.
"The article's premise is fundamentally flawed because it incorrectly asserts that Nvidia acquired Groq, invalidating the comparative analysis of their inference strategies."
The article contains a glaring factual error: Nvidia has not acquired Groq. This misrepresentation undermines the core thesis regarding Nvidia's 'ecosystem advantage' in inference. Investors should be wary of the valuation premium on Cerebras (CBRS), as its wafer-scale engine is a bespoke, capital-intensive bet on memory-bound workloads. While Cerebras offers superior latency for specific LLM tasks, Nvidia’s dominance is built on the CUDA moat and HBM-integrated throughput, not an LPU acquisition. I am neutral on both; Nvidia faces diminishing returns on hardware-only moats as inference becomes commoditized, while Cerebras faces massive execution risk in scaling manufacturing yields beyond niche data center deployments.
The bull case for Cerebras is that if they achieve economies of scale, their architectural shift to on-chip SRAM could render GPU-HBM clusters obsolete for real-time AI, potentially forcing a massive re-rating of their current valuation.
"Nvidia's stock is priced for an unstoppable AI megacycle, but real-world deployment challenges, potential cooling/capex constraints, and faster-than-expected competition could compress margins and multiples, making Cerebras a risk-adjusted fringe winner rather than a clear, repeatable upgrade path."
Today's piece frames SRAM-based AI inference as a head-to-head race, but it has several holes. Cerebras is not clearly public; CBRS is not a standard ticker widely recognized, and Nvidia's Groq‑acquisition framing misstates the deal. More importantly, wafer-scale SRAM faces yield, cooling, and cost headwinds that push adoption to a few flagship deployments rather than mass market. Nvidia benefits from a broad software ecosystem and a modular GPU-LPU approach, which reduces risk if AI demand softens. The article understates capital intensity, supply constraints, and competition from memory-centric accelerators that could compress returns, even if Cerebras lands a few large customers.
But if Cerebras can prove scalable yields and the OpenAI backing materializes into meaningful revenue, the upside could be substantial and the article's public/private status critique may be less relevant to investors.
"Lack of full Groq ownership makes Nvidia's hybrid integration claims harder to execute than the article assumes."
Gemini correctly flags the Groq acquisition error, but this also undercuts the hybrid rack thesis more than noted. Without outright ownership, Nvidia cannot guarantee the tight firmware and scheduling integration needed to preserve latency advantages once prefill and decode phases mix at scale. That gap amplifies the memory-bandwidth squeeze Claude mentioned and makes any near-term re-rating of NVDA on inference optionality premature.
"Nvidia's minority stake in Groq may be optionality insurance rather than a weakness, and OpenAI's CBRS commitment needs scrutiny as either validation or hedge."
Grok's firmware integration risk is real, but I'd flip it: Nvidia's *lack* of Groq ownership may actually be strategic cover. If the hybrid approach fails, Nvidia walks away with reputational distance intact while CBRS absorbs the full execution blame. This asymmetry favors Nvidia even if the technology underperforms. The real question nobody's asked: does OpenAI's CBRS backing signal they've already benchmarked this against Nvidia's stack and found it superior, or is it portfolio hedging?
"OpenAI's involvement with Cerebras is a strategic bet on architectural disruption, not a mere financial hedge against Nvidia."
Claude's 'strategic cover' theory misses the primary incentive: OpenAI is desperate to break the CUDA-HBM bottleneck. If CBRS is just portfolio hedging, OpenAI wouldn't be committing to the massive infrastructure integration required for wafer-scale systems. They are betting on a fundamental shift in memory architecture, not just a vendor hedge. Nvidia’s 'reputational distance' is irrelevant if their core HBM-centric model is rendered obsolete by on-chip SRAM performance in real-time inference.
"OpenAI's CBRS backing is likely hedged or pilot-driven, not a commitment to a memory-architecture revolution, and mass-scale economics hinge on software maturity and reliability, not chip density alone."
Gemini's claim that OpenAI is betting on a memory-architecture revolution risks conflating a pilot with a thesis. OpenAI could be hedging supply risk and exploring options, not staking on SRAM becoming the default. Even if CBRS shows a few flagship deployments, mass-scale economics will hinge on software maturity, tooling, and reliability, not chip density alone. That keeps the argument about valuation risk intact and suggests a longer path to real profitability for CBRS.
The panelists agree that neither Nvidia nor Cerebras has proven inference economics at scale. Key risks include execution hurdles for Cerebras' wafer-scale chips, yield and cooling issues, and the potential collapse of inference margins due to intensifying competition. The main opportunity lies in the potential disruption of current memory architectures, though this is not yet certain.
Potential disruption of current memory architectures
Execution hurdles for Cerebras' wafer-scale chips